Non-invasive uveitis screening, diagnosis and monitoring

Kriba has developed a non-invasive, automatic, AI-powered white blood cell counter that enables worldwide access to accurate screening, diagnosis, monitoring of uveitis, and objective quantification of the disease severity on closed eyelids.

This is an investigational device. It is not for sale. The claims made on this website have not been evaluated by the FDA or the CE Mark authorities.

OUR MISSION

Kriba generates impact on healthcare worldwide by accelerating non-invasive screening, diagnosis and monitoring of uveitis

Uveitis is a major cause of blindness worldwide. Early detection and accurate treatment monitoring of uveitis can prevent dramatic vision loss and eventual blindness.     

Suspecting uveitis can be challenging because it can present asymptomatically in children and infants with juvenile idiopathic arthritis. Uveitis is also missed by the non-expert clinicians in cases of red eye and conjunctivitis, leading to delayed referrals to specialists. Accurate treatment monitoring is also paramount to avoid clinical complications. This is why accurate and objective quantification of the disease severity is needed.

Due to similarities with other ocular condition, misdiagnosis or delayed treatment is possible, moreover, uveitis is often associated with systemic diseases or infections making diagnosis complex.

Low and middle income regions may also have limited access to advanced diagnostic tools and specialized expertise. This can affect timely and accurate detection of uveitis.

Uveitis screening involves counting white blood cells in the fluid behind the cornea and relies on the expertise of the ophtalmologist. The screening process with Neosonics© is done with the eye closed, the cell count is powered by AI, allowing automatic measurement in 30 seconds, and in can be used inmlow, middle and high income countries.

The device will allow the exploration of patients with specific conditions that were difficult to examine before. Its ubiquity in the health system, especially in eye care units, emergency departments and primary care, will improve early detection of uveitis. This will lead to reduced treatment costs and lower rates of blindness and vision loss associated with uveitis.

Cost-
efficient

Cost- efficient

It will save costs associated to hospitalization, negative lumbar punctures, laboratory tests and antibiotic treatment.

Sensitivity and accuracy

High sensitivity and specificity to accurately screen, diagnose and monitor, especially for patients with nonspecific clinical presentations.

Single non-
expert user

Single non-expert user

No expertise and minimum specialization required to perform screening and measurements in less than a minute.

Patient
comfort

Measurements on closed eyelid for patient comfort and probe placement system to switch from eye to eye.

User-
independent

Automated cell count measurement powered by AI

Sensitivity
and accuracy

High sensitivity and specificity to accurately screen, diagnose and monitor, especially for patients with nonspecific clinical presentations.

Treatment
monitoring

It can be used to perform frequent measurements to track white blood cell count evolution, to monitor the patient’s response to treatment.

Cost-
Efficient

Early detection will save costs associated to unnecessary laboratory tests, treatments, hospitalization.

Scientific Publications

Spanish Ocular Inflammation Society Congress - Best Communication Award

2023

Preliminary results of a new system for automatic cellularity detection using high-resolution ultrasound and deep learning in anterior uveitis

Adrià Sánchez-Fortún Sánchez, Francesc Carandell Verdaguer, et al.

Go to PDF

Kriba Eye care

Introducing non-invasive and automatic early detection and quantitative monitoring of uveitis.

Non-invasive uveitis screening, diagnosis and monitoring

OUR MISSION

Kriba generates impact on healthcare worldwide by accelerating non-invasive screening, diagnosis and monitoring of uveitis

Uveitis is a major cause of blindness worldwide. Early detection and accurate treatment monitoring of uveitis can prevent dramatic vision loss and eventual blindness.

Cost-
efficient

Cost- efficient

Sensitivity and accuracy

Single non-
expert user

Single non-expert user

Patient
comfort

User-
independent

Sensitivity
and accuracy

Treatment
monitoring

Cost-
Efficient

Scientific Publications

Kriba Eye care

Stay in touch

WARNING

Are you a healthcare
professional?

Non-invasive uveitis screening, diagnosis and monitoring

OUR MISSION

Kriba generates impact on healthcare worldwide by accelerating non-invasive screening, diagnosis and monitoring of uveitis

Uveitis is a major cause of blindness worldwide. Early detection and accurate treatment monitoring of uveitis can prevent dramatic vision loss and eventual blindness.

Cost- efficient

Cost- efficient

Sensitivity and accuracy

Single non-expert user

Single non-expert user

Patient comfort

User-independent

Sensitivity and accuracy

Treatment monitoring

Cost- Efficient

Scientific Publications

Spanish Ocular Inflammation Society Congress - Best Communication Award

Kriba Eye care

WARNING

Are you a healthcare professional?

Uveitis is a major cause of blindness worldwide. Early detection and accurate treatment monitoring of uveitis can prevent dramatic vision loss and eventual blindness.     

Cost-
efficient

Single non-
expert user

Patient
comfort

User-
independent

Sensitivity
and accuracy

Treatment
monitoring

Cost-
Efficient

Are you a healthcare
professional?